CIDRAP newsletters options
A total of 1,218 fatalities have occurred in New York, the hardest-hit state.
After analyzing a large outbreak at a Seattle-area nursing home, researchers share prevention tips.
A review of published research going back nearly 70 years suggests oral antibiotic step-down therapy is at least as effective as intravenous (IV)-only antibiotics for treating infective endocarditis (IE), US researchers reported today in JAMA Internal Medicine.
US social distancing steps will extend through April.
US activity is surging in New York and several other states and cities.
Also, new studies highlight virus shedding and before-symptom transmission.
The US depends heavily on drugs made in other countries, especially India and China.
A day after topping 500,000 global cases, the total is poised to pass 600,000.
While laboratory-confirmed flu cases continue to decline in the United States, the number of people visiting healthcare providers for influenza-like illness (ILI) rose sharply again last week, according to the Centers for Disease Control and Prevention's (CDC's) latest FluView report today.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The Malaria Consortium yesterday published a paper outlining the steps that the global community needs to take to address antimicrobial resistance (AMR).
Hospitalization rates in Los Angeles and New York City are doubling every few days.
The federal government needs to take leadership to get past our current piecemeal approach to addressing shortages.
Cases are accelerating in multiple hot spots, causing the global total to climb from 400,000 to 500,000 cases in only 2 days.
Chinese researchers say that they can't rule out mother-to-baby transmission in 3 infected newborns.
An international team of surgeons this week released a set of recommendations for preventing surgical-site infections (SSIs) that aim to improve patient outcomes, reduce unnecessary antibiotic exposure, and curb antibiotic resistance in low- and middle-income countries (LMICs).
The bill promises relief for many US households and small businesses.
About 70% of ICU patients got antibiotics, even though only 35% had positive culture tests.
The ECDC says the risk is very high if mitigation measures are inadequate.
Forge Therapeutics announced today that it will partner with Hoffman-La Roche to develop and commercialize a novel antibiotic for treating serious lung infections caused by antibiotic-resistant gram-negative bacteria.
The antibiotic, developed by Forge through its Fg-LpxC LUNG program, targets and inhibits LpxC, a zinc metalloenzyme found in gram-negative bacteria, using a proprietary chemistry platform.
More nations, including the UK and India, order countrywide lockdowns.
